Physician

Rahil Kazi, M.D.

According to 2025 Medicare claims, Rahil Kazi, M.D. (NPI: 1629034079) practices cardiology in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is CENTRAL GEORGIA HEART INSTITUE, LLC (NPI: 1659313153; TIN: 20-1749895) and primary practice location at 31093-3607. Kazi is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Kazi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,599 traditional Medicare patients, billed 12,238 HCPCS/CPT codes, and received $756,831 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,760 prescription claims across 1,096 beneficiaries totaling $1,929,920 in drug costs, led by Eliquis (Apixaban). DME data shows 19 claims. Open Payments data shows 41 records totaling $811. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,078,733 to $756,831. In contrast, Part D prescription costs have moved sharply higher in recent years, from $525,087 to $1,929,920. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $71,549 and ending at $47,143.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,993	18,130	$1,078,733
2016	2,005	18,165	$1,112,594
2017	2,052	18,096	$1,127,964
2018	2,197	18,565	$1,061,933
2019	2,222	18,145	$1,080,861
2020	1,923	15,063	$939,966
2021	1,802	17,510	$1,217,326
2022	1,742	12,784	$776,384
2023	1,691	12,372	$825,148
2024	1,599	12,238	$756,831

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	539	4,958	$525,087
2016	553	4,857	$643,523
2017	580	4,850	$664,620
2018	660	5,154	$783,330
2019	731	5,646	$886,525
2020	754	6,130	$982,872
2021	775	6,233	$1,115,265
2022	794	6,039	$1,247,451
2023	888	6,798	$1,538,216
2024	1,096	8,760	$1,929,920

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	60	$71,930
2016	13	39	$76,317
2017	15	41	$81,061
2018	12	32	$65,615
2019	11	51	$100,963
2020	16	52	$110,105
2021	18	54	$112,256
2022	N/R	28	$64,090
2023	N/R	27	$66,953
2024	N/R	19	$47,143

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	814	839	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,149	2,357	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	964	1,595	$61
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	411	413	$45
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,339	2,326	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	723	43,780	$837,943
Entresto	Sacubitril/Valsartan	272	14,931	$335,306
Repatha Sureclick	Evolocumab	126	6,407	$125,296
Xarelto	Rivaroxaban	90	6,594	$118,259
Farxiga	Dapagliflozin Propanediol	102	6,049	$116,452

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	19	$47,143

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$811	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rahil Kazi, M.D.?

Tedicare shows public-source Medicare data for Rahil Kazi, M.D. (NPI 1629034079), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rahil Kazi, M.D. have ACO affiliation data?

Rahil Kazi, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Rahil Kazi, M.D.?

Rahil Kazi, M.D. is linked to CENTRAL GEORGIA HEART INSTITUE, LLC (billing NPI 1659313153) in the available physician profile data.

Does Rahil Kazi, M.D. have Open Payments data?

Rahil Kazi, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.